Pacira Pharma (PCRX) Set to Join S&P SmallCap 600 (Earlier)
Pacira BioSciences Inc. (NASD: PCRX) will replace Shutterfly Inc. (NASD: SFLY) in the S&P SmallCap 600 effective prior to the open of trading on Monday, September 30. Apollo Global Management Inc. (NYSE: APO) is acquiring Shutterfly in a transaction expected to be completed tomorrow pending final conditions.
Pacira BioSciences provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients. Headquartered in Parsippany, NJ, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Pharmaceuticals Sub-Industry index.
Following is a summary of the change:
S&P SMALLCAP 600 INDEX – September 30, 2019 | |||
COMPANY | GICS ECONOMIC SECTOR | GICS SUB-INDUSTRY | |
ADDED | Pacira BioSciences | Health Care | Pharmaceuticals |
DELETED | Shutterfly | Consumer Discretionary | Internet & Direct Marketing Retail |